RT Journal Article
SR Electronic
T1 Development of clinical virtual care pathways to engage and support families requiring neonatal intensive care in response to the COVID-19 pandemic (COVES Study)
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.29.21254567
DO 10.1101/2021.03.29.21254567
A1 Campbell-Yeo, Marsha
A1 Dol, Justine
A1 Richardson, Brianna
A1 McCulloch, Holly
A1 Hundert, Amos
A1 Foye, Sarah
A1 Dorling, Jon
A1 Afifi, Jehier
A1 Bishop, Tanya
A1 Earle, Rebecca
A1 Rose, Annette Elliott
A1 Inglis, Darlene
A1 Kim, Theresa
A1 Leighton, Carye
A1 Loring, Sally
A1 MacRae, Gail
A1 Melanson, Andrea
A1 Simpson, David C
A1 Smit, Michael
A1 Whitehead, Leah
YR 2021
UL http://medrxiv.org/content/early/2021/03/31/2021.03.29.21254567.abstract
AB Background In response to the COVID-19 pandemic, family presence restrictions in neonatal intensive care units (NICU) were enacted to limit disease transmission and protect infants, families, and healthcare providers. The effects of pandemic parental restrictions on providing optimal family integrated neonatal care is unknown.Aim To ensure optimal neonatal care using virtual care pathways to engage and support families in response to parental presence restrictions imposed during the COVID-19 pandemic. The research had two objectives: (1) conduct a needs assessment with families and healthcare providers (HCPs) of infants in the NICU to understand the impact of COVID-19 restrictions; and (2) develop virtual clinical care pathways to meet identified needs.Methods This study used focus groups and individual semi-structured interviews with families and HCPs for the needs assessment and identification of barriers and facilitators, and co-design for the development of the clinical virtual care pathways. For objective 1, content analysis was conducted by two independent reviewers to categorize findings and identify important barriers and facilitators of family-integrated care. For objective 2, an agile, co-design process utilizing expert consensus of a large interdisciplinary team was used to develop the care pathways.Results A total of 23 participants were included in the needs assessment (objective 1): 12 families and 11 HCPs. Themes identified were: (1) the need to maintain and build relationships and support systems; (2) challenges in accessing education and resources to integrate families in care; and (3) lack of standardized, accessible messaging related to COVID-19. For objective 2, we used the themes identified in the needs assessment to co-design three clinical virtual care pathways: (1) building and maintaining relationships between family and healthcare providers; (2) awareness of resources; and (3) standardized COVID-19 messaging.Conclusion Families reported that restrictive parental presence policies affected their mental health, well-being and social support. Families and HCPs reported the restrictions impacted delivery of family integrated care, education, transition to home, and standardized messaging. Clinical care virtual pathways were designed to meet these needs to ensure more equitable family centred care.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding for this project was from the Nova Scotia COVID-19 Health Research Coalition through the IWK Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval was received through IWK Health prior to recruitment (REB #1025748).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from the corresponding author, [MCY], upon reasonable request.